Solara Active Pharma Sciences has reported results for first quarter ended June 30, 2024 (Q1FY25).
The company has reported net loss at Rs 12.32 crore for the quarter ended June 30, 2024 as compared to net loss of Rs 19.88 crore for the same quarter in the previous year. However, total income of the company increased by 2.96% at Rs 364.87 crore for Q1FY25 as compared to Rs 354.38 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported net loss at Rs 13.46 crore for Q1FY25 as compared to net loss of Rs 19.11 crore for the same quarter in the previous year. However, total income of the company increased by 2.74% at Rs 364.05 crore for Q1FY25 as compared to Rs 354.35 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1786.85 |
Dr. Reddys Lab | 1173.55 |
Cipla | 1525.50 |
Lupin | 2018.35 |
Zydus Lifesciences | 859.10 |
View more.. |